v3.26.1
DERIVATIVE ASSETS AND DERIVATIVE LIABILITIES
 6 Months Ended
Mar. 31, 2026
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE ASSETS AND DERIVATIVE LIABILITIES DERIVATIVE ASSETS AND DERIVATIVE LIABILITIES
Our derivative assets and derivative liabilities are recorded at fair value and are included in “Derivative assets” and “Derivative liabilities” on our Condensed Consolidated Statements of Financial Condition. Cash flows related to our derivatives are included within operating activities on the Condensed Consolidated Statements of Cash Flows. The significant accounting policies governing our derivatives, including our methodologies for determining fair value, are described in Note 2 of our 2025 Form 10-K.

Derivative balances included on our financial statements

The following table presents the gross fair values and notional amounts of derivatives by product type, the amounts of counterparty and cash collateral netting on our Condensed Consolidated Statements of Financial Condition, as well as collateral posted and received under credit support agreements that do not meet the criteria for netting under GAAP.
March 31, 2026September 30, 2025
$ in millionsDerivative assetsDerivative liabilitiesNotional amountDerivative assetsDerivative liabilitiesNotional amount
Derivatives not designated as hedging instruments
Interest rate (1)
$275 $281 $20,547 $306 $309 $20,446 
Foreign exchange3 — 525 — 2 539 
Other— — 973 — 2 1,096 
Subtotal278 281 22,045 306 313 22,081 
Derivatives designated as hedging instruments
Interest rate
— — 400 — — 850 
Foreign exchange
7 — 1,258 1 — 1,242 
Subtotal
7 — 1,658 1 — 2,092 
Total gross fair value/notional amount
285 281 $23,703 307 313 $24,173 
Offset on the Condensed Consolidated Statements of Financial Condition
Counterparty netting
(61)(61)(92)(92)
Cash collateral netting
(153)(22)(147)(31)
Total amounts offset
(214)(83)(239)(123)
Net amounts presented on the Condensed Consolidated Statements of Financial Condition
$71 $198 $68 $190 
Gross amounts not offset on the Condensed Consolidated Statements of Financial Condition
Financial instruments
(1)— (1)— 
Total
$70 $198 $67 $190 

(1)Included to-be-announced security contracts that are accounted for as derivatives.

The following table details the gains/(losses) included in AOCI, net of income taxes, on derivatives designated as hedging instruments. These amounts do not include any offsetting gains/(losses) on the related hedged item. These gains/(losses) included any amounts reclassified from AOCI to net income during the period. See Note 18 for additional information.
 Three months ended March 31,Six months ended March 31,
$ in millions2026202520262025
Interest rate (cash flow hedges)$— $(5)$(2)$1 
Foreign exchange (net investment hedges)16 3 6 60 
Total gains/(losses) included in AOCI, net of taxes
$16 $(2)$4 $61 

There were no components of derivative gains or losses excluded from the assessment of hedge effectiveness for each of the three and six months ended March 31, 2026 and 2025. We expect to reclassify $6 million of interest expense out of AOCI and into earnings within the next 12 months. The maximum length of time over which forecasted transactions are or will be hedged is two years.
The following table details the gains/(losses) on derivatives not designated as hedging instruments recognized on the Condensed Consolidated Statements of Income and Comprehensive Income. These amounts do not include any offsetting gains/(losses) on the related hedged item.
$ in millionsThree months ended March 31,Six months ended March 31,
Location of gains/(losses)
2026202520262025
Interest rate
Principal transactions/other revenue
$3 $4 $6 $7 
Foreign exchange (1)
Principal transactions/other revenue
$9 $(13)$8 $48 
OtherPrincipal transactions$1 $8 $3 $2 

(1)The impacts included in our Condensed Consolidated Statements of Income and Comprehensive Income of these amounts net of the gains/(losses) on the related hedged item were net gains of $1 million and $2 million for the three months ended March 31, 2026 and 2025, respectively, and net gains of $3 million and $4 million for the six months ended March 31, 2026 and 2025, respectively.

Risks associated with our derivatives and related risk mitigation

Credit risk

We are exposed to credit losses primarily in the event of nonperformance by the counterparties to derivatives that are not cleared through a clearing organization. Where we are subject to credit exposure, we perform a credit evaluation of counterparties prior to entering into derivative transactions and we continue to monitor their credit standings on an ongoing basis.  We may require initial margin or collateral from counterparties, generally in the form of cash or marketable securities to support certain of these obligations as established by the credit threshold specified by the agreement and/or as a result of monitoring the credit standing of the counterparties. We also enter into derivatives with clients, typically interest rate derivatives, to which either of our bank subsidiaries have provided loans. Such derivatives are generally collateralized by marketable securities or other assets of the client.

Interest rate and foreign exchange risk

We are exposed to interest rate risk related to certain of our interest rate derivatives. We are also exposed to foreign exchange risk related to our forward foreign exchange derivatives.  On a daily basis, we monitor our risk exposure on our derivatives based on established sensitivity-based and foreign exchange spot limits.

Derivatives with credit-risk-related contingent features

Certain of our derivative contracts contain provisions that require our debt to maintain an investment-grade rating from one or more of the major credit rating agencies or contain provisions related to default on certain of our outstanding debt. If our debt were to fall below investment-grade or we were to default on certain of our outstanding debt, the counterparties to the derivative instruments could terminate the derivative and request immediate payment or demand immediate and ongoing overnight collateralization on our derivative instruments in liability positions. The aggregate fair value of all derivative instruments with such credit-risk-related contingent features that were in a liability position was not significant at either March 31, 2026 or September 30, 2025.